(Q44611995)

English

Lansoprazole reduces ulcer relapse after eradication of Helicobacter pylori in nonsteroidal anti‐inflammatory drug users – a randomized trial

scientific article published on October 15, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Lansoprazole reduces ulcer relapse after eradication of Helicobacter pylori in nonsteroidal anti-inflammatory drug users--a randomized trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Lansoprazole reduces ulcer relapse after eradication of Helicobacter pylori in nonsteroidal anti‐inflammatory drug users – a randomized trial (English)

1 reference

10.1046/J.1365-2036.2003.01762.X

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01762.X

19 March 2024

0 references

Helicobacter pylori

1 reference

based on heuristic

inferred from title

author name string

Wong BC

6

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

K. C. Lai

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14535877

19 March 2024

S. K. Lam

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14535877

19 March 2024

K. M. Chu

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14535877

19 March 2024

W. M. Hui

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14535877

19 March 2024

K. F. Kwok

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14535877

19 March 2024

B. C Y. Wong

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14535877

19 March 2024

H. C. Hu

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14535877

19 March 2024

W. M. Wong

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14535877

19 March 2024

O. O. Chan

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14535877

19 March 2024

C. K. Chan

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14535877

19 March 2024

language of work or name

0 references

publication date

1 October 2003

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

15 October 2003

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14535877

19 March 2024

full work available at URL

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1365-2036.2003.01762.x

1 reference

10.1046/J.1365-2036.2003.01762.X

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01762.X

19 March 2024

https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1365-2036.2003.01762.x

1 reference

10.1046/J.1365-2036.2003.01762.X

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01762.X

19 March 2024

Alimentary Pharmacology & Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

18

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

829-836

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01762.X

21 January 2018

Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01762.X

21 January 2018

Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01762.X

21 January 2018

Role of Helicobacter pylori infection on upper gastrointestinal bleeding in the elderly: a case-control study.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01762.X

21 January 2018

Eradication of Helicobacter pylori and risk of peptic ulcers in patients starting long-term treatment with non-steroidal anti-inflammatory drugs: a randomised trial

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01762.X

21 January 2018

Relative contribution of mucosal injury and Helicobacter pylori in the development of gastroduodenal lesions in patients taking non-steroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01762.X

21 January 2018

Risk of upper gastrointestinal bleeding and perforation associated with Individual non-steroidal anti-inflammatory drugs

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01762.X

21 January 2018

Risk for Serious Gastrointestinal Complications Related to Use of Nonsteroidal Anti-inflammatory Drugs

1

1 reference

10.1046/J.1365-2036.2003.01762.X

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01762.X

19 March 2024

Nitrovasodilators, low-dose aspirin, other nonsteroidal antiinflammatory drugs, and the risk of upper gastrointestinal bleeding

4

1 reference

10.1046/J.1365-2036.2003.01762.X

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01762.X

19 March 2024

Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: a review

6

1 reference

10.1046/J.1365-2036.2003.01762.X

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01762.X

19 March 2024

A Multiple Testing Procedure for Clinical Trials

9

1 reference

10.1046/J.1365-2036.2003.01762.X

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01762.X

19 March 2024

Helicobacter pylori and risk of ulcer bleeding among users of nonsteroidal anti-inflammatory drugs: A case-control study☆, ☆☆

10

1 reference

10.1046/J.1365-2036.2003.01762.X

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01762.X

19 March 2024

Peptic ulcer bleeding in the elderly: relative roles of Helicobacter pylori and non-steroidal anti-inflammatory drugs

11

1 reference

10.1046/J.1365-2036.2003.01762.X

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01762.X

19 March 2024

Helicobacter pylori infection is a protective factor for bleeding gastric ulcers but not for bleeding duodenal ulcers in NSAID users

13

1 reference

10.1046/J.1365-2036.2003.01762.X

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01762.X

19 March 2024

Effect of treatment of Helicobacter pylori on the prevention of gastroduodenal ulcers in patients receiving long-term NSAIDs: a double-blind, placebo-controlled trial

15

1 reference

10.1046/J.1365-2036.2003.01762.X

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01762.X

19 March 2024

Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study. Helicobacter Eradication for Lesion Prevention

16

1 reference

10.1046/J.1365-2036.2003.01762.X

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01762.X

19 March 2024

Prevention of peptic ulcer and dyspeptic symptoms with omeprazole in patients receiving continuous non-steroidal anti-inflammatory drug therapy. A Nordic multicentre study

17

1 reference

10.1046/J.1365-2036.2003.01762.X

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01762.X

19 March 2024

Primary gastroduodenal prophylaxis with omeprazole for non-steroidal anti-inflammatory drug users

18

1 reference

10.1046/J.1365-2036.2003.01762.X

https://api.crossref.org/works/10.1046/J.1365-2036.2003.01762.X

19 March 2024

Identifiers

10.1046/J.1365-2036.2003.01762.X

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44611995&oldid=2108521865"